In summary, during acute inflammation B cell-inhibition attenuates the pro-inflammatory effect of B cells whereas in case of chronic inflammation in atherosclerosis restraining of B cells via mTOR inhibition could hamper protective antibody expression against oxLDL. Here, MTOR is linked to atherosclerosis.